selpercatinib
eli lilly
['solid tumor', 'selpercatinib']
selpercatinib demonstrates promising activity in ret fusion-positive solid tumors - #googlealerts #asco2022 #retrenegadew
LUNGevity’s “RET Renegades” shares resources for lung cancer patients impacted by the RET mutation. Information, resources and advocacy can be found here.